Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al<sup>18</sup>F/<sup>68</sup>Ga/<sup>111</sup>In
The Al<sup>18</sup>F-labeling approach offers a one-step access to radiofluorinated biomolecules by mimicking the labeling process for radiometals. Although these labeling conditions are considered to be mild compared to classic radiofluorinations, improvements of the chelating units have led to the discovery of <b>(±)-H</b><sub><b>3</b></sub><b>RESCA</b>, which allows Al<sup>18</sup>F-labeling already at ambient temperature. While the suitability of <b>(±)-H</b><sub><b>3</b></sub><b>RESCA</b> for functionalization and radiofluorination of proteins is well established, its use for small molecules or peptides is less explored. Herein, we advanced this acyclic pentadentate ligand by introducing an alkyne moiety for the late-stage functionalization of biomolecules via click chemistry. We show that in addition to Al<sup>18</sup>F-labeling, the cyclohexanediamine triazole (CHDT) moiety allows stable complexation of <sup>68</sup>Ga and <sup>111</sup>In. Three novel CHDT-functionalized PSMA inhibitors were synthesized and their Al<sup>18</sup>F-, <sup>68</sup>Ga-, and <sup>111</sup>In-labeled analogs were subjected to a detailed <i>in vitro</i> radiopharmacological characterization. Stability studies <i>in vitro</i> in human serum revealed among others a high kinetic inertness of all radiometal complexes. Furthermore, the Al<sup>18</sup>F-labeled PSMA ligands were characterized for their biodistribution in a LNCaP derived tumor xenograft mouse model by PET imaging. One radioligand, <b>Al[</b><sup><b>18</b></sup><b>F]F-CHDT-PSMA-1</b>, bearing a small azidoacetyl linker at the glutamate-urea-lysine motif, provided an <i>in vivo</i> performance comparable to that of <b>[</b><sup><b>18</b></sup><b>F]PSMA-1007</b> but with even higher tumor-to-blood and tumor-to-muscle ratios at 120 min <i>p.i.</i> Overall, our results highlight the suitability of the novel CHDT moiety for functionalization and radiolabeling of small molecules or peptides with Al<sup>18</sup>F, <sup>68</sup>Ga, and <sup>111</sup>In and the triazole ring seems to entail favorable pharmacokinetic properties for molecular imaging purposes.
Authors
- Anne-Kathrin Nitt-Weber
- Wiebke Sihver (ORCID: https://orcid.org/0000-0002-2876-9925)
- Robert Wodtke (ORCID: https://orcid.org/0000-0001-7462-7111)
- Kristof Zarschler (ORCID: https://orcid.org/0000-0002-7571-4732)
- Martin Walther (ORCID: https://orcid.org/0000-0002-0474-8492)
- Klaus Kopka (ORCID: https://orcid.org/0000-0003-4846-1271)
- Hans‐Jürgen Pietzsch (ORCID: https://orcid.org/0000-0001-5286-4319)
- Christin Neuber (ORCID: https://orcid.org/0000-0002-0646-5808)
- Martin Ullrich (ORCID: https://orcid.org/0000-0001-6104-6676)
- Falco Reissig (ORCID: https://orcid.org/0000-0002-5203-0776)
- Jens Pietzsch (ORCID: https://orcid.org/0000-0002-1610-1493)
- Jenny Böhme
- Magdalena Saager
- Jörg Steinbach
Institutions
- Helmholtz-Zentrum Dresden-Rossendorf (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Bioconjugate Chemistry
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1021/acs.bioconjchem.4c00313
- Citations
- 5
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.02
Funders
- Technische Universität Dresden
- Helmholtz-Zentrum Dresden-Rossendorf